6mw3211
mAbexperimentalBi-specific
Clinical trial activity
4 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Jul 7, 2022 (NCT05448599)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
- Multi-specific
- Yes (Bi-specific)
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05440045 | Phase 2 | Sep 1, 2022 | Mabwell |
| NCT05446688 | Phase 2 | Sep 1, 2022 | Jiao Tong University, Mabwell |
| NCT05431569 | Phase 2 | Jul 10, 2022 | Mabwell |
| NCT05448599 | Phase 1 | Jul 7, 2022 | Henan Medical University, Mabwell |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Mabwell | For profit | 4 | 4 | 2 | 2022 |
| Henan Medical University | Academic/Hospital | 1 | 0 | 1 | 2022 |
| Jiao Tong University | Academic/Hospital | 1 | 0 | 1 | 2022 |
3 organizations
Page 1 / 1